Everest Medicines, a China-based biopharmaceutical company, has commenced operations at its mRNA vaccine production plant in Jiashan, Zhejiang Province, thereby becoming a fully-integrated biopharma. With the first phase going live, Everest Medicines now owns complete pharmaceutical and vaccine value chain from discovery, clinical development, manufacturing, and commercialization. The first phase of the vaccine manufacturing facility […]
Panacea Biotec, an Indian biotechnology company, has been awarded supply orders worth $127.3 million from United Nations Children’s Fund (UNICEF) and Pan American Health Organization (PAHO) for the supply of Easyfive-TT (DTwP-HepB-Hib), pentavalent vaccine. The award from UNICEF is for supplying nearly 99.7 million doses of Easyfive-TT vaccine during calendar years 2023-2027 and is worth […]
Moderna has signed an agreement in principle with the Government of Australia to build a messenger RNA (mRNA) vaccine manufacturing plant in Victoria. According to the US biotech company, the planned framework will lay the foundation to help Australia get direct access to rapid response capabilities to pandemics as well as to gain access to […]
The Russian Direct Investment Fund (RDIF), the Russian sovereign wealth fund, has entered into a partnership with Indian pharma company Wockhardt Limited for producing and distributing the Sputnik V and Sputnik Light vaccines against Covid-19. The agreement was signed under the watch of Enso Healthcare, part of Enso Group, which is the coordination partner of […]
Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated vaccine against SARS-CoV2, has demonstrated efficacy of 77.8% against symptomatic Covid-19 in phase 3 clinical trials. Efficacy analysis of the Bharat Biotech vaccine showed that it was 93.4% effective against severe symptomatic Covid-19. Against asymptomatic Covid-19, the […]
Wipro has entered into a partnership with Transcell Oncologics with an objective to transform safety assessments of vaccines by leveraging augmented intelligence (AI). The partnership will bring together the stem cell technology of Transcell Oncologics with the advanced augmented intelligence capabilities of Wipro HOLMES for enhancing the safety of vaccination programs across the world. Dr. […]
Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed COVID-19 vaccine candidate. The agreement will be subject to a final contract issued by the British government. The COVID-19 vaccine candidate has been developed by Sanofi in partnership with British […]
US pharma giant Pfizer has initiated four phase 3 clinical trials within its present pipeline of investigational vaccines. The company’s 20vPnC, which is a 20-valent pneumococcal polysaccharide conjugate vaccine candidate, will be evaluated in two phase 3 trials NCT04382326 and NCT04379713. Both the late-stage trials will evaluate a four-dose series in infants starting at the […]
Researchers at the University of Oxford in the UK have commenced the ChAdOx1 nCoV-19 vaccine trial in healthy human volunteers to test the vaccine candidate’s ability in protecting against the novel coronavirus. Nearly 1,100 people, aged between 18 and 55 are taking part in the Oxford University coronavirus vaccine trial, of which half of them […]
French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their drug discovery technologies. Sanofi will provide its S-protein Covid-19 antigen based on recombinant DNA technology to the partnership. The technology is said to be used for generating an exact genetic […]
